Overview
miRNAs are small but mighty, playing a significant role in gene expression regulation. There’s mounting evidence of their potential as disease biomarkers, which has driven extraordinary developments in cancer, metabolic and disease research. However, miRNA profiling research is often hindered by low RNA amounts and high levels of inhibitors, especially in biofluid samples. This has triggered a demand for dedicated solutions optimized for miRNA research – from high-quality miRNA extraction to efficient miRNA sequencing for miRNA expression insights. Advance your miRNA research by partnering with QIAGEN and benefitting from our high-performance miRNA solutions and expertise.
Featured success story
Product details
Discuss your project needs with us
Get expert advice on your miRNA projects.
Resources
Check out the webinars
Key publications
- Farr, R. et al. (2021) Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.
- Karvinen, S. et al. (2021) Estradiol deficiency and skeletal muscle apoptosis: Possible contribution of microRNAs. Experimental Gerontology (147), 111267.
- Lv, A., Tu, z., Huang, Y., Lu, W., and Xie, B. (2020) Circulating exosomal miR‑125a‑5p as a novel biomarker for cervical cancer. Oncol Lett 21: 54.
-
Wang, X. et al. (2020) Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials. PLoS ONE 15(8): e0237401.
Services
Contact us
Get in touch with our specialists to discuss your miRNA-seq project needs.